We are live on ! Find out more
N

Nuveen Portfolio holdings

AUM $369B
1-Year Est. Return 31.66%
This Fund
S&P 500
This Quarter Est. Return
+13.71%
1 Year Est. Return
+31.66%
3 Year Est. Return
+110.02%
5 Year Est. Return
+148.02%
10 Year Est. Return
+492.84%
AUM
$311B
AUM Growth
+$27B
Cap. Flow
-$2.73B
Cap. Flow %
-0.88%
Top 10 Hldgs %
26.14%
Holding
3,413
New
219
Increased
1,869
Reduced
1,057
Closed
98

Top Buys

Rank Stock Value
1
CRH icon
CRH
CRH
+$482M
2
SHOP icon
Shopify
SHOP
+$353M
3
INTC icon
Intel
INTC
+$318M
4
NKE icon
Nike
NKE
+$312M
5
UBS icon
UBS Group
UBS
+$309M

Top Sells

Rank Stock Value
1
AMZN icon
Amazon
AMZN
+$520M
2
ORCL icon
Oracle
ORCL
+$471M
3
CRM icon
Salesforce
CRM
+$452M
4
EOG icon
EOG Resources
EOG
+$360M
5
META icon
Meta Platforms (Facebook)
META
+$246M

Sector Composition

Rank Sector Weight
1 Technology 28.65%
2 Financials 12.19%
3 Healthcare 11.7%
4 Consumer Discretionary 11.15%
5 Industrials 8.94%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
SAMG icon
3101
Silvercrest Asset Management
SAMG
$80.5M
$318K ﹤0.01%
18,724
+4,705
+34% +$77.7K
COFS icon
3102
Choiceone Financial
COFS
$514M
$317K ﹤0.01%
+10,831
New +$253K
MPX
3103
DELISTED
Marine Products Corp
MPX
$317K ﹤0.01%
27,813
+8,636
+45% +$97.5K
GWH icon
3104
ESS Tech
GWH
$19.8M
$315K ﹤0.01%
18,440
+2,520
+16% +$51.2K
KC
3105
Kingsoft Cloud Holdings
KC
$3.69B
$314K ﹤0.01%
83,200
SWIM icon
3106
Latham Group
SWIM
$888M
$309K ﹤0.01%
117,384
+15,966
+16% +$39.5K
THRD
3107
DELISTED
Third Harmonic Bio
THRD
$307K ﹤0.01%
27,963
+1,139
+4% +$9.02K
VKI icon
3108
Invesco Advantage Municipal Income Trust II
VKI
$400M
$305K ﹤0.01%
+36,132
New +$283K
SEAT icon
3109
Vivid Seats
SEAT
$85.8M
$301K ﹤0.01%
2,384
CARM
3110
DELISTED
Carisma Therapeutics
CARM
$301K ﹤0.01%
102,702
+2,914
+3% +$8.66K
MLYS icon
3111
Mineralys Therapeutics
MLYS
$2.41B
$300K ﹤0.01%
34,831
+15,676
+82% +$123K
PAMT
3112
PAMT Corp
PAMT
$284M
$299K ﹤0.01%
14,375
+172
+1% +$3.35K
KZR
3113
DELISTED
Kezar Life Sciences
KZR
$298K ﹤0.01%
31,476
+119
+0.4% +$1.05K
PAA icon
3114
Plains All American Pipeline
PAA
$16.1B
$297K ﹤0.01%
19,633
MVF
3115
DELISTED
BlackRock MuniVest Fund
MVF
$297K ﹤0.01%
+41,753
New +$271K
ESCA icon
3116
Escalade
ESCA
$314M
$294K ﹤0.01%
14,629
+1,627
+13% +$30.1K
BLE
3117
DELISTED
BlackRock Municipal Income Trust II
BLE
$293K ﹤0.01%
+27,389
New +$268K
CFFI icon
3118
C&F Financial
CFFI
$281M
$287K ﹤0.01%
4,213
TSBK icon
3119
Timberland Bancorp
TSBK
$357M
$286K ﹤0.01%
9,087
RELL icon
3120
Richardson Electronics
RELL
$304M
$286K ﹤0.01%
21,406
+5,943
+38% +$71K
FOA icon
3121
Finance of America Companies
FOA
$198M
$283K ﹤0.01%
25,762
+628
+2% +$6.45K
STKS icon
3122
The ONE Group
STKS
$53.7M
$279K ﹤0.01%
45,600
+465
+1% +$2.3K
RSKD icon
3123
Riskified
RSKD
$709M
$279K ﹤0.01%
+59,563
New +$244K
DTF
3124
DTF Tax-Free Income 2028 Term Fund
DTF
$81.1M
$276K ﹤0.01%
+25,688
New +$275K
SSBK
3125
DELISTED
Southern States Bancshares
SSBK
$275K ﹤0.01%
9,401

Similar funds

Nuveen's Q4 2023 Portfolio in Review

As of Q4 2023, Nuveen held 3,413 positions worth $311B, up 9.5% from $284B the previous quarter. Its ten largest holdings account for 26% of the portfolio.

Nuveen's Q4 2023 filing shows 219 new, 1,869 increased, 1,057 reduced and 98 closed positions. Its largest new stake was CRH: 7,989,897 shares worth $552M. The largest sale was Amazon, an estimated $520M.

By sector, the portfolio is most concentrated in Technology at 29% of assets, up from 27% a quarter earlier, followed by Financials and Healthcare.

  • Nuveen's largest Q4 2023 buy was CRH: 7,989,897 shares worth $552M.
  • Nuveen added most to Intel in Q4 2023, an estimated $318M increase.
  • Nuveen's biggest Q4 2023 reduction was Amazon, cutting an estimated $520M.
  • Nuveen fully exited Activision Blizzard in Q4 2023, selling an estimated $194M.
  • Nuveen's ten largest holdings make up 26% of its $311B portfolio in Q4 2023.
  • Nuveen opened 219 new positions and closed 98 in Q4 2023.
  • Nuveen's portfolio value rose 9.5% quarter-over-quarter to $311B.

Based on Nuveen's 13F filing for Q4 2023, filed 14 Feb 2024.